Study details
Enrolling now
Stereotactic Radiosurgery Dose Escalation for Brain Metastases
University of Utah
NCT IDNCT02390518ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
50
Study length
about 11 years
Ages
18+
Locations
1 site in UT
What this study is about
This trial is testing a treatment called stereotactic radiosurgery to see how much radiation can be safely given to people with brain metastases who have never had radiation before. The goal is to find the highest dose that patients can tolerate.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Stereotactic Radiosurgery
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Maximum Tolerated Dose of stereotactic radiosurgery
Procedures
radiation